C14orf124 Activators refers to a collection of chemical agents specifically formulated to interact with and enhance the biological activity of the protein produced by the gene C14orf124, situated on the 14th chromosome. By definition, these activators are designed to influence the protein's function, potentially by fostering protein synthesis, aiding in protein folding and stability, or by promoting interactions with other cellular components. The pursuit of such activators commences with a thorough exploration of the protein's structure and operational domains, which often involves a combination of bioinformatics for predictive modeling and empirical techniques like X-ray crystallography to elucidate the protein's three-dimensional conformation. High-throughput screening methods would then be applied to vast chemical libraries to discover molecules that can modulate the function of C14orf124, with subsequent rounds of chemical optimization refining these initial hits into more potent and selective activators.
In parallel with the search for chemical activators, a deeper investigation into the biological role of the C14orf124 protein is essential, as this knowledge would inform the activator design process, ensuring that such molecules are tailored to the most functionally relevant regions of the protein. Methods such as affinity purification, proteomics, and functional genomics could be instrumental in identifying interaction partners and pathways associated with C14orf124, thus providing context for its cellular role. Computational approaches, including molecular docking and dynamics, would complement these methods by simulating potential activator interactions, offering predictive insights that can streamline the development of effective compounds. Through these concerted efforts, a series of C14orf124 Activators could be developed, each designed to modulate the protein's activity in a cellular environment, contributing to a broader understanding of the protein's contribution to cellular function without reference to its potential for addressing any specific medical conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid affects gene expression and can modulate the expression of enzymes involved in metabolism, potentially including SDR39U1. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ is essential for the activity of SDR enzymes; an increase in its availability might upregulate SDR39U1 expression to balance redox reactions. | ||||||
β-Nicotinamide adenine dinucleotide phosphate | 53-59-8 | sc-215560 sc-215560A | 100 mg 250 mg | $182.00 $319.00 | ||
NADP+ serves as a cofactor for SDR enzymes. Its increased concentration may signal the need for more SDR enzymes, like SDR39U1. | ||||||
D(+)Glucose, Anhydrous | 50-99-7 | sc-211203 sc-211203B sc-211203A | 250 g 5 kg 1 kg | $38.00 $198.00 $65.00 | 5 | |
Glucose metabolism alters the cellular redox state and requires the action of multiple dehydrogenases, potentially influencing SDR39U1 expression. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
As a steroid, hydrocortisone is metabolized by various SDRs, and its presence could potentially induce the expression of SDR39U1. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Metabolites of vitamin D are processed by dehydrogenases; thus, vitamin D levels might influence SDR39U1 expression. | ||||||
Butyric acid | 107-92-6 | sc-214640 sc-214640A | 1 kg 10 kg | $64.00 $177.00 | ||
Butyrate is a short-chain fatty acid metabolized by SDRs, and its metabolism could regulate SDR39U1 expression. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
As an antifungal that affects steroid biosynthesis, ketoconazole might alter SDR39U1 expression by affecting steroid metabolism. | ||||||